Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cogent Biosciences Inc.

    NASDAQ: COGT · Real-Time Price · USD
    7.10
    -0.14 (-1.93%)
    At close: Jun 25, 2025, 3:59 PM
    7.15
    0.70%
    After-hours: Jun 25, 2025, 07:36 PM EDT

    Cogent Biosciences Statistics

    Share Statistics

    Cogent Biosciences has 113.86M shares outstanding. The number of shares has increased by 19.07% in one year.

    Shares Outstanding

    n/a
    		 113.86M

    Shares Change (YoY)

    n/a
    		 19.07%

    Shares Change (QoQ)

    n/a
    		 3.07%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 94.03M

    Failed to Deliver (FTD) Shares

    n/a
    		 68

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 14.31M, so 12.56% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 14.31M

    Short % of Shares Out

    n/a
    		 12.56%

    Short % of Float

    n/a
    		 14.71%

    Short Ratio (days to cover)

    n/a
    		 9.86

    Valuation Ratios

    The PE ratio is -3.17 and the forward PE ratio is -3.8. Cogent Biosciences's PEG ratio is -0.07.

    PE Ratio

    n/a
    		 -3.17

    Forward PE

    n/a
    		 -3.8

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.4

    PB Ratio

    n/a
    		 3.16

    P/FCF Ratio

    n/a
    		 -3.89

    PEG Ratio

    n/a
    		 -0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Cogent Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.32, with a Debt / Equity ratio of 0.07.

    Current Ratio

    n/a
    		 5.32

    Quick Ratio

    n/a
    		 5.32

    Debt / Equity

    n/a
    		 0.07

    Debt / EBITDA

    n/a
    		 -0.06

    Debt / FCF

    n/a
    		 -0.08

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,248,092.68

    Employee Count

    n/a
    		 205

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -12.86% in the last 52 weeks. The beta is 0.23, so Cogent Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.23

    52-Week Price Change

    n/a
    		 -12.86%

    50-Day Moving Average

    n/a
    		 5.52

    200-Day Moving Average

    n/a
    		 8.09

    Relative Strength Index (RSI)

    n/a
    		 65.27

    Average Volume (20 Days)

    n/a
    		 1,657,977

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -275.94M

    Net Income

    n/a
    		 -255.86M

    EBITDA

    n/a
    		 -275.94M

    EBIT

    n/a
    		 -275.94M

    Earnings Per Share (EPS)

    n/a
    		 -3.49
    Full Income Statement

    Balance Sheet

    The company has 98.17M in cash and 17.47M in debt, giving a net cash position of 80.7M.

    Cash & Cash Equivalents

    n/a
    		 98.17M

    Total Debt

    n/a
    		 17.47M

    Net Cash

    n/a
    		 80.7M

    Retained Earnings

    n/a
    		 -859.48M

    Total Assets

    n/a
    		 283.8M

    Working Capital

    n/a
    		 203.57M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -207.79M and capital expenditures -573K, giving a free cash flow of -208.36M.

    Operating Cash Flow

    n/a
    		 -207.79M

    Capital Expenditures

    n/a
    		 -573K

    Free Cash Flow

    n/a
    		 -208.36M

    FCF Per Share

    n/a
    		 -2.01
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    COGT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for COGT is $13.5, which is 86.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $13.5

    Price Target Difference

    n/a
    		 86.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 9, 2020. It was a backward split with a ratio of 1:4.

    Last Split Date

    n/a
    		 Nov 9, 2020

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:4

    Scores

    Altman Z-Score

    n/a
    		 -1.94

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist